Inventor · disambiguated record
Yi Yong Baek
Also filed as: BAEK YI YONG
7 granted patents·4 pending applications·2 citations·filing 2016–2021
72Inventor score
Files withAVIXGEN INC11
Top patents by PatentIndex Score
11 records- 0181US9969771B2Tetrapeptide having effect of inhibiting VEGF-induced angiogenesis and use thereofAVIXGEN INC·Filed 2016·Granted May 15, 2018·2 cites·6 claims
- 0267US11702449B2Angiogenesis-inhibiting peptide and composition for preventing and treating angiogenesis-related disease comprising same as active ingredientAVIXGEN INC·Filed 2021·Granted Jul 18, 2023·0 cites·6 claims
- 0367US10821101B2Pharmaceutical composition for preventing or treating AIDS comprising rhodanine derivativeAVIXGEN INC·Filed 2019·Granted Nov 3, 2020·0 cites·3 claims
- 0463US11547649B2Fusion protein bound to cell-permeable peptide, and composition comprising fusion protein or cell-permeable peptide and epithelial cell growth factor as active ingredientsAVIXGEN INC·Filed 2019·Granted Jan 10, 2023·0 cites·5 claims
- 0563US2021388029A1Cytoplasmic transduction peptide and intracellular messenger comprising sameAVIXGEN INC·Filed 2021·Application pending·0 cites
- 0659US11141407B2Pharmaceutical composition for preventing or treating aids comprising rhodanine derivativeAVIXGEN INC·Filed 2020·Granted Oct 12, 2021·0 cites·3 claims
- 0758US11208433B2Peptide for inhibiting skin inflammation and composition for preventing or treating skin inflammation containing the sameAVIXGEN INC·Filed 2018·Granted Dec 28, 2021·0 cites·8 claims
- 0851US11040999B2Angiogenesis-inhibiting peptide and composition for preventing and treating angiogenesis-related disease comprising same as active ingredientAVIXGEN INC·Filed 2016·Granted Jun 22, 2021·0 cites·13 claims
- 0950US2019315809A1Cytoplasmic transduction peptide and intracellular messenger comprising sameAVIXGEN INC·Filed 2017·Application pending·0 cites
- 1044US2021106662A1Pharmaceutical composition for treating severe complex immunodeficiency comprising fusion protein of cell penetrating peptide and adenosine deaminaseAVIXGEN INC·Filed 2019·Application pending·0 cites
- 1143US2021254037A1Pharmaceutical composition comprising fusion protein of cell-penetrating peptide and rpe65 for treatment of leber's congenital amaurosisAVIXGEN INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →